MALAT1 and hepatocellular carcinoma: One study reported that in HCC, targeting MALAT-1 via shRNAs downregulates the expression of MALAT-1 and Wnt, indicating that MALAT-1 induces cell stemness and decreases differentiation through the Wnt pathway [125].